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Transient receptor potential melastatin subfamily member 4
(TRPM4) is a widely distributed, calcium-activated, monovalent-
selective cation channel. Mutations in human TRPM4 (hTRPM4)
result in progressive familial heart block. Here, we report the
electron cryomicroscopy structure of hTRPM4 in a closed, Na+-
bound, apo state at pH 7.5 to an overall resolution of 3.7 Å. Five
partially hydrated sodium ions are proposed to occupy the center
of the conduction pore and the entrance to the coiled-coil domain.
We identify an upper gate in the selectivity filter and a lower gate
at the entrance to the cytoplasmic coiled-coil domain. Intramolec-
ular interactions exist between the TRP domain and the S4–
S5 linker, N-terminal domain, and N and C termini. Finally, we
identify aromatic interactions via π–π bonds and cation–π bonds,
glycosylation at an N-linked extracellular site, a pore-loop disulfide
bond, and 24 lipid binding sites. We compare and contrast this
structure with other TRP channels and discuss potential mecha-
nisms of regulation and gating of human full-length TRPM4.
ion channel | transient receptor potential channel | cardiac arrhythmia |
cryomicroscopy
Transient receptor potential (TRP) channels are permeable tocations, with most conducting both monovalent and divalent
ions (1). TRP melastatin subfamily member 4 (TRPM4) and
TRPM5 have the distinction among TRPM channels of being
activated by, but impermeable to, Ca2+ (2, 3), with preferred
conduction for Na+ > K+ > Cs+ > Li+ >> Ca2+, Cl−. Under
physiological conditions its single-channel conductance is 25 pS
(4, 5). Activation is modulated by PI(4,5)P2, PKC phosphoryla-
tion, calcium, and calmodulin (6, 7). TRPM4 channel blockers
include intracellular nucleotides such as ATP, ADP, AMP, and
AMP-PNP (adenylyl-imidodiphosphate), with IC50s of 1.3 to
1.9 μM (8).
TRPM4 is widely expressed in many tissues, and appears to be
an important regulator of dendritic cell migration, mast cells,
lymphocytes, pancreatic β-cells, neurons, and smooth muscle
cells in the vasculature and bladder (9–13). TRPM4 has also
been shown to be important for proper activation in heart con-
duction pathways (14, 15); it is active in the late phase of re-
polarization of the cardiac ventricular action potential and
enhances beta adrenergic-mediated inotropy. Mutations are as-
sociated with conduction defects (16–18), resembling those as-
sociated with mutations in the cardiac voltage-gated Na+ channel
NaV1.5 (SCN5A) (19–22).
During preparation of this manuscript, three cryo-EM struc-
tures of the TRPM4 channel were reported (23–25): hTRPM4 in
lipid nanodiscs with and without calcium bound at ∼3 Å (25),
and another bound to decavanadate at ∼3.5 Å (23). Here, we
present the cryo-EM structure of full-length human TRPM4 at
an overall resolution of 3.7 Å, with putative Na+ ions in the
conduction pathway. We provide additional information to the
recently published structures, with details on subunit interac-
tions, domain arrangement, sodium selectivity, and binding sites
in the structure of TRPM4.
Structure of Human TRPM4
Full-length human TRPM4 (1,214 residues) was expressed using
the BacMam expression system (Materials and Methods). The
TRPM4 construct used for expression retained the key func-
tional properties of the wild-type channel, such as permeability
to Na+ and K+ and activation by intracellular calcium (Fig. S1A).
The protein, obtained in the absence of exogenous calcium ions,
eluted as a monodisperse peak in 0.1% (wt/vol) digitonin during
gel filtration; the peak fraction was subjected to structure de-
termination by cryo-EM (Fig. S1B). We calculated the structure
of the TRPM4 tetramer from 61,653 particles selected from an
initial dataset of 244,216 particle images recorded on a direct
electron detector. From these particles, we obtained a map of
TRPM4 with an overall resolution of 3.7 Å, as estimated by a
Fourier shell correlation of 0.143 (Fig. S2 and Table S1). The
local resolution of the transmembrane domain is 3.5 Å. At this
resolution, we were able to build an atomic model for the S1 to
S6 region and the N- and C-terminal domains de novo, without
reference to other TRP channel structures (Fig. S3).
The tetrameric TRPM4 ion channel overall dimensions were
150 × 120 × 120 Å, consisting of N-terminal cytosolic domains, a
transmembrane domain with six membrane-spanning helices per
monomer, and C-terminal domains (Fig. 1 A–D). The first four
transmembrane domain helices (S1 to S4) are followed by a pore
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domain with two long helices (S5 and S6) linked by a pore helix.
The transmembrane domain has four prominent features:
(i) The TRP domain contains two helices, one long following S6 and
one short connecting with the C-terminal domain (Fig. 1 E and
F); (ii) the voltage-sensor domain (VSD) lacks the four argi-
nine residues on S4 that are responsible for the strong voltage
sensing in classic voltage-gated sodium and potassium channels
(26, 27). The two conserved arginine residues (Arg892 and
Arg905) found at either end of S4 contribute little to voltage
sensitivity (Figs. S4 and S5); (iii) a long pore loop between
S5 and S6 (66 residues, amino acids 951 to 1,016); and (iv) a
short helix between S2 and S3 (S2–S3 linker), lying parallel to
the inner layer of the plasma membrane (Fig. 1 E and F). The
density of the intracellular S2–S3 loop in the overall
TRPM4 structure is poorly resolved, indicating potential dy-
namic motion. Beyond these features, the most striking dif-
ference between TRPM4 and other TRP channel subfamily
members is an ∼700-amino acid-long N-terminal domain that
interacts with the TRP domain, pre-S1 helix, and C-terminal
domain. The C-terminal domain is also unique in that a
connecting helix bridges the TRP domain and the conserved
coiled-coil domain (Fig. S5).
Six cholesteryl hemisuccinates (CHSs) per monomer are evi-
dent in the tetrameric TRPM4, embedded in the hydrophobic
transmembrane regions. As expected, CHS hydrophilic regions
face extracellularly or intracellularly, while their hydrophobic
tails face the transmembrane region (Fig. S6). We also observe
an extracellular glycosylation site at N992 on each monomer
(Fig. S7) and two cysteines, C993 and C1011, forming a disulfide
bond in the pore loop (Fig. S7). The disulfide bond is adjacent to
the glycosylation site and near the initiation of S6, perhaps in-
dicating a site for small-molecule recognition or redox sensitivity.
Domain Interactions
The TRP domain commonly plays a role in channel activation
and allosteric modulation (28, 29). In TRPM4, the TRP domain
makes contact with the S4–S5 linker via hydrogen bonding,
similar to that in TRPV1 and TRPA1 (30–32). N913 on the S4–
S5 linker forms hydrogen bonds with R1062 on the TRP domain
(Fig. 2A). The polar interactions between the TRP domain and
N-terminal domain are extensive, involving three positively
charged residues (K1059, R1062, and R1067) and two hydro-
phobic residues (L1056 and Y1063) on the TRP domain, and
L655, Q673, T677, and R664 of the N-terminal domain (Fig. 2 B
and C). The N-terminal domain also interacts with the con-
necting helix in the C-terminal domain. This helix bridges the
N- and C-terminal domains (Fig. 2D), indicating its potential
importance for TRPM4 subunit assembly.
TRPM4: Aromatic Interactions
Aromatic interactions, such as π–π interactions, are important in
protein folding and thermal stability (33). In particular, two or-
dered aromatic π–π stacks are present in TRPM4’s trans-
membrane domain. The aromatic ring planes of F793 on S1 and
F902 on S4 form an edge-to-face π–π interaction (Fig. 3A). A
face-to-face π–π stack, 4.2 Å from the ring centroid, is observed
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Fig. 1. Overall structure of human full-length TRPM4 in the apo state.
(A and B) Side (A) and top (B) views of the cryo-EM reconstruction density
map of human TRPM4 at 3.7-Å overall resolution; each subunit is color-coded.
(C and D) Ribbon diagrams representing the same orientation and colors with
the channel’s dimensions indicated. (E) Structural details of a single human
TRPM4 subunit. (F) Linear diagram depicting the major structural domains,
color-coded to match the ribbon diagram. The N-linked N992 glycosylation site
(N-G) and the Cys993–Cys1011 disulfide bond are indicated.
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Fig. 2. Detailed domain interactions of human TRPM4. Interactions be-
tween (A) the TRP domain and S4–5 linker, (B) TRP domain and N terminus,
(C) N terminus and pre-S1 helix, and (D) N and C termini. Residues at domain
interfaces are labeled with hydrogen bonds and electrostatic interactions as
dashed lines.
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in Y944 near the end of S5 and F1027 on S6 (Fig. 3B). Similar
π–π interactions are not observed in TRPV1, but in TRPA1 the
S5 helix’s F884 forms π–π interactions with F944 on the S6 helix in a
similar position as in TRPM4, suggesting relevant interhelical
interactions (30).
Cation–π interactions are as important as hydrogen bonding,
hydrophobic effects, and ion pairing in determining protein
structures (34). Several cation–π interactions are present in
TRPM4 structures. In the S1–S2 loop, F805 interacts with R882 in
the S3–S4 loop (Fig. 3C), and R955 interacts with W1000 within
the pore loop (Fig. 3D). Another two pairs of cation–π interac-
tions are located on the TRP domain (Y1063/R1067, F1069/
R1072), with Y1063/R1067 making polar interactions with the
N-terminal domain (Fig. 3E). These interactions with the TRP
domain should facilitate allosteric coupling.
Cytosolic Domains
The N- and C-terminal domains of ion channels are usually cy-
tosolic. In TRPM4, the four C termini form a homotetramer via
parallel coiled coils, sitting directly below the pore. Interestingly,
preceding each coiled-coil helix is an ∼25-amino acid connecting
helix that bends ∼120° to form an inverted “L” with the coiled-
coil helix (Fig. 4A, Left). The four connecting helix subunits are
perpendicular to each other when viewed from the top, and link
with the coiled coils to form a central hole (Fig. 4A, Right). At
the top of this hole, the side chain of S1143 forms a hydrogen
bond with the backbone of D1144 on the adjacent helix, with the
four hydrogen bonds stabilizing the coiled coil. Two leucines and
one glutamate interaction “boxes” in the coiled-coil hole stabi-
lize the structure. These consist of leucines (L1148) forming
hydrophobic interactions at 3.6 Å, L1162 forming hydrophobic
interactions at 3.5 Å, and E1169 forming a hydrogen bond at
2.9 Å (Fig. 4B).
The N-terminal region of TRPM4 shields the coil-coiled do-
main (Fig. 4C). The proximal N terminus contains five β-sheets
and six α-helices forming a relatively independent subdomain
(Fig. 4D), followed by ankyrin-like repeats (Fig. 4D). Two long
helices and one short helix form a stable connecting subdomain
that interacts with the C terminus and supports the trans-
membrane domain. Three short helices and several loops form a
linker subdomain extending to the transmembrane domain (Fig.
4D). Notably, a short helix in the linker subdomain (amino acids
P689 to A696; PIWALVLA) is hydrophobic and anchors to the
inner leaflet of the plasma membrane (Fig. 4 C and D, arrows).
The Ion Conduction Pathway
Two gates control TRPM4’s conduction: 975FGQ977 in the se-
lectivity filter and I1040 at the intracellular gate (Fig. 5 A and B).
In the apo state, both gates appear to be closed (Fig. 5 A and B).
The three-residue motif (975FGQ977) of the TRPM4 selectivity
filter is highly conserved in TRPM2, TRPM5, and TRPM8, while
FGE/YGE are the corresponding residues in TRPM1, TRPM3,
TRPM6, and TRPM7 (Fig. S5). In TRPM4, the side chains of
Q977 and the backbone carbonyls of G976 and F975 pointing
into the ion pathway form the external entrance to the central
cavity (Fig. 5A). The external entrance of the ion conduction
pathway is electronegative, presumably concentrating cations
(Fig. 5 C and D). The pore selectivity filter dimensions, defined
by the diagonal side-chain carbonyl oxygens of Q977 and the
main-chain carbonyl oxygens of G976, are 7.4 and 6.0 Å, re-
spectively (Fig. S8). In our structure, the most restricted site in
the ion permeation pathway is the lower gate (Fig. 5 A and B),
formed by the diagonal side chains of S6’s I1040 at 5.1 Å and
S1044 at 5.2 Å (Fig. S8).
At the top of the permeation pathway, in the linker between
the pore helix and S6, are an N-linked N992 glycosylation site
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Fig. 3. Aromatic interactions of human TRPM4. Ribbon diagrams showing
aromatic interactions of human TRPM4: π–π bonds (A and B) and cation–π
bonds (C–E). Residues and helices at these interactions are labeled.
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and a conserved disulfide bond (C993–C1011; Fig. 1F and Fig. S7).
The extracellular entrance to the ion conduction pathway is
electronegative, as noted above (Fig. 5 C and D). Four spherical
nonprotein densities in the map are present in the ion conduction
pathway and at the periplasmic cytosolic exit of the channel.
Surprisingly, the fifth and strongest spherical density is found in
the entrance of the coiled-coil domain in the C terminus. Since the
only cation in the purification buffer is sodium, we suspect that the
densities in the 40-Å-long pore are hydrated Na+ (Na1 to 5; Fig.
6), but we cannot exclude the possibility that potassium ions could
normally occupy the site at the cytosolic surface. Na1 and Na2 are
surrounded by the side chains of Q977 and the main-chain pore-
loop carbonyls of G976 and F975 (Fig. 6B, Upper). The distance
between Na1 and Na2 and the carbonyls of G976 is 3.4 and 4.9 Å,
respectively, consistent with a partially hydrated Na+ (hydrated
radius, 2.4 Å). The four backbone carbonyl oxygens of G976 co-
ordinate the putative Na+ in the Na2 site just below the selectivity
filter. Na3 and Na4 are located within the lower gate (Fig. 6B,
Middle). Na3 is recognized by the backbone carbonyl groups of
I1040 and the side chains of S1044. Just below Na3, Na4 interacts
with the main-chain carbonyl groups and the side chains of S6’s
S1044. The isoleucine in the lower gate of the ion conduction
pathway is highly conserved within the TRPM subfamily, whereas
the serine, S1044, is only found in the monovalent-preferring chan-
nels, TRPM4 and TRPM5 (Fig. S5). Thus, S1044 might contribute
to specific TRPM4/5 gating. Finally, Na5 is located in the C-terminal
coiled-coil entrance and is recognized by the backbone carbonyl
groups of S1143 and the side chains of the negatively charged D1144
(Fig. 6B, Lower).
Discussion
We describe human full-length TRPM4’s apo structure with den-
sities in its conduction pathway that are consistent with Na+ ions.
Confirmed human disease-related mutations associated with pro-
gressive familial heart block type IB [PFHB1B; OMIM (Online
Mendelian Inheritance in Man) 604559] are mapped onto the
structure in Fig. S9. There are several phenotypes in TRPM4-
deficient mice, including abnormal cardiac conduction (17, 35),
hypertension (36), more severe IgE-mediated acute immune
responses (13), and inflammation-induced neurodegeneration
and spinal cord injury in the central nervous system (12, 37).
Overall, the structures in the four independent publications (23–
25) are similar, with variability, as expected, in the more flexible and
thus lower-resolution N terminus (Fig. S10). We attribute the five
central path densities to sodium ions, although structure–function
studies and/or crystallography should be carried out to confirm this
hypothesis (Fig. S10A). Six cholesteryl hemisuccinates, a lipid an-
ionic detergent used in purification, are seen per monomer in the
region between the VSD and pore domain (Fig. S10A), indicating
potential lipid binding sites. We also point out interactions between
domains (Fig. 2) and aromatic (π–π and cation–π) interactions (Fig.
3) that were not described in detail in the other publications. Our
primary aim was to shed light on the mechanism of the TRPM4
channel’s relative selectivity for monovalent cations compared with
other TRP channels. TRPM4 and TRPM5 are ∼40% identical and
the most closely related of the TRPM family. Both are permeable
to monovalent ions such as Na+ and K+, but poorly conduct
divalent ions.
TRPM4’s ion selectivity filter and lower gate are identified
as G976 and I1040, respectively. In mammalian voltage-gated
Na+-selective channels, positively charged lysine residues in the
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axis. The side chains of Q977 to F975 form a narrow constriction at the se-
lectivity filter, while I1040 is the most restricted site of the lower gate. Side
(C) and bottom (D) views of the electrostatic map. The surface is colored
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Fig. 6. Putative sodium binding sites of human TRPM4. Overall (A) and
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Five nonprotein densities, consistent with partially hydrated Na+ ions, along
the pore and at the entrance of the coiled-coil domain, are indicated as
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sites. The key amino acid residues are labeled, and interactions between the
ions and binding sites are shown as dashed lines.
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pore’s “DEKA” motif mediate sodium selectivity by a combi-
nation of size restriction and charge. Interestingly, there are
two positively charged residues, Arg965 and Arg969, located in
the pore helix of TRPM4/5, which are not found in the other,
nonselective, TRPMs. Since the serine at 1044 is only found in
the Na+-selective TRPM4 and TRPM5 channels (e.g., aspar-
agine in TRPM1 to TRPM3, TRPM6, and TRPM7), this res-
idue should be tested for effects on gating. Given its exposed
location, it might also be phosphorylated to alter conduction.
Human TRPM4’s structure also offers interesting insight into
its assembly and regulation, including details of domain inter-
actions and aromatic interactions in TRPM4’s apo state, TRP
domain interactions with the S4–S5 linker and the N-terminal domain,
N–C termini interactions, and the Cys993–Cys1011 disulfide bond in
the pore loop. These all provide interesting starting points to
examine potential regulators of gating.
Materials and Methods
Protein Expression and Purification. The full-length human TRPM4 construct
(amino acids 1 to 1,214) was cloned into the pEG BacMam vector (38), and a
maltose-binding protein tag was added to its N terminus. P3 baculovirus was
produced in the Bac-to-Bac Baculovirus Expression System (Invitrogen).
HEK293S GnTI− cells were infected with 10% (vol/vol) P3 baculovirus at a
density of 2.0 to 3.0 × 106 cells per mL for protein expression. After 12 to
24 h, 10 mM sodium butyrate was added and the temperature was reduced
to 30 °C. Cells were harvested at 72 h after transduction, and resuspended in
a buffer containing 30 mM Hepes, 150 mM NaCl, and 1 mM DTT (pH 7.5)
with EDTA-free protease inhibitor mixture (Roche) for 30 min followed by
solubilization for 2 to 3 h in a buffer containing 1.0% (wt/vol) N-dodecyl-
beta-D-maltopyranoside (Affymetrix), 0.1% (wt/vol) cholesteryl hemisuccinate
(Sigma), 30 mM Hepes, 150 mM NaCl, and 1 mM DTT (pH 7.5) with EDTA-free
protease inhibitor mixture (Roche). The supernatant was isolated by 100,000 ×
g centrifugation for 60 min, followed by incubation in amylose resin (New
England BioLabs) at 4 °C overnight. The resin was washed with 20 column
volumes of washing buffer containing 25mMHepes, 150 mMNaCl, 0.1% (wt/vol)
digitonin, 0.01% (wt/vol) CHS, and 1 mM DTT (pH 7.5) with EDTA-free protease
inhibitor mixture (Roche). The protein was eluted with four column volumes of
washing buffer with 40 mM maltose. The protein was then concentrated to
0.5 mL with a 100-kDa molecular mass cutoff concentrator (Millipore) before
further purification on a Superose 6 column in a buffer composed of 25 mM
Hepes, 150 mM NaCl, 0.1% (wt/vol) digitonin, and 1 mM DTT (pH 7.5). The
peak, corresponding to tetrameric TRPM4, was collected and concentrated to
7.8 mg/mL for electron cryomicroscopy.
Electron Microscopy Data Collection. Purified human TRPM4 protein (3.5 μL) in
digitonin buffer at 7.8 mg/mL was applied onto a glow-discharged, 400-
mesh copper Quantifoil R1.2/1.3 holey carbon grid. Grids were blotted for 7 s
at 100% humidity and flash-frozen by liquid nitrogen-cooled liquid ethane
using an FEI Vitrobot Mark I. The grid was then loaded onto an FEI TF30
Polara electron microscope operating at 300 kV accelerating voltage. Image
stacks were recorded on a Gatan K2 Summit direct detector set in super-
resolution counting mode using SerialEM (39), with a defocus range be-
tween 1.5 and 3.0 μm. The electron dose was set to 8 e−·physical pixel−1·s−1
and the subframe time to 200 ms. A total exposure time of 10 s resulted in
50 subframes per image stack. The total electron dose was 52.8 e− per Å2
(∼1.1 e− per Å2 per subframe).
Image Processing and 3D Reconstruction. Image stacks were gain-normalized
and binned by 2× to a pixel size of 1.23 Å before drift and local movement
correction using MotionCor2 (40). The images from the sum of all frames
with dose weighting were subjected to visual inspection and poor images
were removed before particle picking. Particle picking and subsequent bad
particle elimination through 2D classification were performed using Python
scripts/programs (41) with minor modifications in the 8× binned images. The
selected 2D class averages were used to build an initial model using the
common lines approach implemented in SPIDER (42) through Maofu Liao’s
Python scripts (41), which was applied to later 3D classification using RELION
(43). The contrast transfer function (CTF) parameters were estimated using
CTFFIND4 (44) using the sum of all frames without dose weighting. Quality
particle images were then boxed out from the dose-weighted sum of all
50 frames and subjected to RELION 3D classification. RELION 3D refinements
were then performed on selected classes for the final map. The resolution of
this map was further improved by using the sum of subframes 1 to 14.
Model Building, Refinement, and Validation. For the full-length protein, a poly-
alanine model was first built in Coot (45). Taking advantage of the defined
geometry of helices and clear bumps for Cα atoms in the transmembrane
domain, amino acid assignment was subsequently achieved based primarily on
the clearly defined side-chain densities of bulky residues. Resolution of the first
part of the N-terminal domain was insufficient for backbone tracing, and
hence the polyalanine model was used for that region. The refined atomic
model was further visualized in Coot. A few residues with side chains moving
out of the density during the refinement were fixed manually, followed by
further refinement. The TRPM4 model was then subjected to global re-
finement andminimization in real space using the PHENIX (46) module phenix.
real_space_refine (47), and geometries of the model were assessed using
MolProbity (48) in the comprehensive model validation section of PHENIX. The
final model exhibited good geometry, as indicated by the Ramachandran plot
(preferred region, 90.42%; allowed region, 9.33%; outliers, 0.25%). The pore
radius was calculated using HOLE (49).
Electrophysiology. Whole-cell currents were recorded from the same cells
used for protein expression as described above. Recordings were conducted
at room temperature with an Axopatch 200B patch-clamp amplifier con-
trolled via a Digidata 1440A (Molecular Devices). Patch pipettes of 2 to 5 MΩ
contained 156 mM CsCl, 1 mM MgCl2, 10 mM CaCl2, 10 mM EGTA, and
10 mM Hepes, yielding 10 μM free calcium (calculated with https://web.
stanford.edu/∼cpatton/webmaxcS.htm) (pH 7.4). The saline bath solution
contained 140 mM NaCl, 4.8 mM KCl, 1.2 mM MgCl2, 10 mM glucose, and
10 mM Hepes (pH 7.4). TRPM4 current was inhibited using 9-phenanthrol at
10 μM. Cells were held at 0 mV, and 200-ms ramps from −100 to 100 mV
were applied every 2 s. Currents were digitized at 10 kHz and low-pass-fil-
tered at 2 kHz.
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